₹ 99.05
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Lactose India Ltd. specializes in the production of a wide array of pharmaceutical items. Its product portfolio encompasses excipients, solid and liquid dosage forms, Active Pharmaceutical Ingredients (APIs), and prebiotic galacto-oligosaccharides. The company was established on March 11, 1991, and operates from its headquarters in Mumbai, India.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITD.
Data is available to registered users only